Role of the receptor Mas in macrophage-mediated inflammation in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 49, 2016, Pages 14109-14114

  Hammer, Anna ^a   Yang, Guang ^b   Friedrich, Juliane ^a   Kovacs, Agnes ^a   Lee, De Hyung ^a   Grave, Katharina ^b   Jörg, Stefanie ^a   Alenina, Natalia ^c   Grosch, Janina ^a   Winkler, Jürgen ^a   Gold, Ralf ^d   Bader, Michael ^c,e,f,g,h   Manzel, Arndt ^a   Rump, Lars C ^b   Müller, Dominik N ^c,g   Linker, Ralf A ^a   Stegbauer, Johannes ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d RUHR UNIVERSITY BOCHUM   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^g UNIVERSITY OF LÜBECK   (Germany)

^h BERLIN INSTITUTE OF HEALTH   (Germany)

Author keywords

Atherosclerosis; EAE; Inflammation; Macrophages; Renin angiotensin system

Indexed keywords

ANGIOTENSIN[1-7]; APOLIPOPROTEIN E; MAS RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PROTO-ONCOGENE PROTEINS C-MAS-1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CELL INFILTRATION; CONTROLLED STUDY; GENE EXPRESSION; HYPOCHOLESTEROLEMIA; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; POLARIZATION; PRIORITY JOURNAL; SPINAL CORD; SPLEEN; T LYMPHOCYTE ACTIVATION; ANIMAL; C57BL MOUSE; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNOLOGY; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; MACROPHAGES; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD; SPLEEN; T-LYMPHOCYTES;

EID: 85002057655     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1612668113     Document Type: Article

References (39)

1. Burnier M, Brunner HR (2000) Angiotensin II receptor antagonists. Lancet 355(9204): 637-645.
2. Kim S, Iwao H (2000) Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 52(1):11-34.
3. Guzik TJ, et al. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204(10):2449-2460.
4. Muller DN, et al. (2002) Immunosuppressive treatment protects against angiotensin IIinduced renal damage. Am J Pathol 161(5):1679-1693.
5. Platten M, et al. (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 106(35):14948-14953.
6. Stegbauer J, et al. (2009) Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system. Proc Natl Acad Sci USA 106(35): 14942-14947.
7. Esteban V, et al. (2003) Effect of simultaneous blockade of AT1 and AT2 receptors on the NFkappaB pathway and renal inflammatory response. Kidney Int 64(Suppl 86): S33-S38.
8. Mii A, et al. (2009) Angiotensin II receptor blockade inhibits acute glomerular injuries with the alteration of receptor expression. Lab Invest 89(2):164-177.
9. Kostenis E, et al. (2005) G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111(14):1806-1813.
10. Santos RAS, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G proteincoupled receptor Mas. Proc Natl Acad Sci USA 100(14):8258-8263.
11. Metzger R, et al. (1995) Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett 357(1):27-32.
12. Jiang F, et al. (2014) Angiotensin-converting enzyme 2 and angiotensin 1-7: Novel therapeutic targets. Nat Rev Cardiol 11(7):413-426.
13. Santos RA (2014) Angiotensin-(1-7). Hypertension 63(6):1138-1147.
14. Xu P, et al. (2008) Endothelial dysfunction and elevated blood pressure in MAS genedeleted mice. Hypertension 51(2):574-580.
15. Brosnihan KB, Li P, Ferrario CM (1996) Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 27(3 Pt 2):523-528.
16. Sampaio WO, et al. (2007) Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49(1):185-192.
17. Potthoff SA, et al. (2014) Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice. Hypertension 63(2):265-272.
18. Stegbauer J, et al. (2011) Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice. Br J Pharmacol 163(5): 974-983.
19. Souza LL, Costa-Neto CM (2012) Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages. J Cell Physiol 227(5):2117-2122.
20. Herrero-Herranz E, Pardo LA, Gold R, Linker RA (2008) Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis. Neurobiol Dis 30(2):162-173.
21. Wassmann S, et al. (2004) Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 110(19):3062-3067.
22. Murray PJ, et al. (2014) Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41(1):14-20.
23. Thomas MC, et al. (2010) Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 107(7):888-897.
24. Gallagher PE, Tallant EA (2004) Inhibition of human lung cancer cell growth by angiotensin-( 1-7). Carcinogenesis 25(11):2045-2052.
25. Strawn WB, Ferrario CM, Tallant EA (1999) Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 33(1 Pt 2):207-211.
26. Tallant EA, Ferrario CM, Gallagher PE (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 289(4):H1560-H1566.
27. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD (2005) Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 11(3):335-339.
28. Combadière C, et al. (2008) Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117(13):1649-1657.
29. Tacke F, et al. (2007) Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 117(1):185-194.
30. El-Hashim AZ, et al. (2012) Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways. Br J Pharmacol 166(6):1964-1976.
31. Ueda A, Ishigatsubo Y, Okubo T, Yoshimura T (1997) Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. J Biol Chem 272(49):31092-31099.
32. Cassetta L, Cassol E, Poli G (2011) Macrophage polarization in health and disease. ScientificWorldJournal 11:2391-2402.
33. Liu Y-C, Zou X-B, Chai Y-F, Yao Y-M (2014) Macrophage polarization in inflammatory diseases. Int J Biol Sci 10(5):520-529.
34. Moreno M, et al. (2014) Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J Neurosci 34(24):8175-8185.
35. Smith JD, et al. (1995) Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA 92(18): 8264-8268.
36. Walther T, et al. (1998) Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene. J Biol Chem 273(19):11867-11873.
37. Haghikia A, et al. (2015) Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity 43(4):817-829.
38. Muccioli M, Pate M, Omosebi O, Benencia F (2011) Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies. J Vis Exp (52):e2785.
39. Stegbauer J, Oberhauser V, Vonend O, Rump LC (2004) Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovasc Res 61(2):352-359.